Orthofix edges closer to US cervical spine sector
This article was originally published in Clinica
Executive Summary
Eyeing a market that represents a "significant" opportunity for growth, Orthofix International has filed in the US important trial data for expanding the use of its noninvasive bone growth stimulation method to the cervical spine fusion sector.